retatrutide investigational drug weight loss Lilly's triple agonist achieves 16.8% in phase 3 trial Why Retatrutide Is Gaining Attention
Description
Practicing proper oral hygiene can help lower these risks
When used under medical supervision and combined with healthy lifestyle habits, peptide-based treatments may help support sustainable weight management
For some, that marginal gain matters
The primary analysis included all patients with at least one follow-up visit after the index date
Who is an appropriate candidate for GLP-1 agonists for weight loss
One systematic review reported that use of exenatide 20 mcg twice daily resulted in an additional 1.4 kg weight loss, whilst exenatide 2 mg once weekly was associated with 1.6 kg additional weight loss compared with placebo [30]
